Top pharma group seeks postmortem on lobbying after drug pricing loss

Washington’s top pharmaceutical lobby is doing some self-reflection, commissioning a report that looks at its advocacy in the runup to its most consequential legislative loss in decades. Megan R. Wilson talks with Alice Miranda Ollstein about the upcoming report. Learn more about your ad choices. Visit megaphone.fm/adchoices